Inventor · disambiguated record
Mickaël Terme
Also filed as: TERME MICKAEL · TERME MICKAËL
6 granted patents·2 pending applications·5 citations·filing 2014–2023
71Inventor score
Files withOGD2 PHARMA8
Top patents by PatentIndex Score
8 records- 0171US10745489B2Targeting o-acetylated gd2 ganglioside as a new therapeutic and diagnostic strategy for Cancer Stem Cells cancerOGD2 PHARMA·Filed 2018·Granted Aug 18, 2020·1 cites·12 claims
- 0269US11697689B2Use of antibody against O-acetylated GD2 ganglioside to improve the therapeutic potential of drugsOGD2 PHARMA·Filed 2017·Granted Jul 11, 2023·1 cites·18 claims
- 0369US2023148349A1Humanized antibody against o-acetylated gd2 ganglioside (oacgd2)OGD2 PHARMA·Filed 2022·Application pending·0 cites
- 0467US10611848B2Antibody against GD2-O-acetylated ganglioside with pro-apoptotic activityOGD2 PHARMA·Filed 2014·Granted Apr 7, 2020·1 cites·23 claims
- 0567US10000575B2Targeting O-acetylated GD2 ganglioside as a new therapeutic and diagnostic strategy for cancer stem cells cancerOGD2 PHARMA·Filed 2014·Granted Jun 19, 2018·2 cites·11 claims
- 0663US2023416398A1Use of antibody against o-acetylated gd2 ganglioside to improve the therapeutic potential of drugsOGD2 PHARMA·Filed 2023·Application pending·0 cites
- 0759US11440968B2Humanized antibody against O-acetylated GD2 ganglioside (OAcGD2)OGD2 PHARMA·Filed 2017·Granted Sep 13, 2022·0 cites·21 claims
- 0845US10669328B2Human IgG1 derived antibody with pro-apoptotic activityOGD2 PHARMA·Filed 2014·Granted Jun 2, 2020·0 cites·25 claims
Join the waitlist — get patent alerts
Get an alert when Mickaël Terme files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →